Carson Wealth (CWM LLC)
ELTX icon

Carson Wealth (CWM LLC)’s Elicio Therapeutics ELTX Stock Holding History

Carson Wealth (CWM LLC)’s Portfolio ELTX Stock Details ELTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-100
Closed -$1K – 4422
2023
Q4 		$1K Sell
100
-250
-71% -$1.63K ﹤0.01% 3943
2023
Q3 		$3K Hold
350
– – ﹤0.01% 3655
2023
Q2 		$3K Buy
+350
New +$3.21K ﹤0.01% 3626

Other funds holding ELTX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CM
CM Management Gulf Breeze, Florida $157M AUM 60.08% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
MHC
Meyer Handelman Company Rye Brook, New York $3.53B AUM 30.49% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $5.69B AUM 60.64% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
CIBC Private Wealth Group
CIBC Private Wealth Group Atlanta, Georgia $59.2B AUM 20.62% 1-Year Est. Return
SPIA
Steward Partners Investment Advisory New York $19.6B AUM 29.84% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Carson Wealth (CWM LLC)'s ELTX Position: Q1 2024 in Review

Carson Wealth (CWM LLC) sold out of Elicio Therapeutics (ELTX) in Q1 2024, closing a stake of 100 shares — an estimated $1K sold.

Carson Wealth (CWM LLC) first reported a position in ELTX in Q2 2023 and held it in 3 quarters. The position peaked at $3K in Q3 2023. 18 funds tracked by Wall St. Rank hold ELTX as of Q1 2024.

  • Carson Wealth (CWM LLC) reported no remaining Elicio Therapeutics position as of Q1 2024 after selling out during the quarter.
  • Carson Wealth (CWM LLC) sold 100 Elicio Therapeutics shares in Q1 2024, an estimated $1K.
  • Carson Wealth (CWM LLC) first reported a position in Elicio Therapeutics in Q2 2023 and held it in 3 quarters.
  • Carson Wealth (CWM LLC)'s Elicio Therapeutics position peaked at $3K in Q3 2023.
  • 18 funds tracked by Wall St. Rank held Elicio Therapeutics as of Q1 2024.

Based on Carson Wealth (CWM LLC)'s 13F filing for Q1 2024, filed 5 Apr 2024.